Top compounds associated with response to PNPO


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.077 0.02
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.082 0.02
mRNA lapatinib CTRPv2 pan-cancer AAC 0.084 0.02
mRNA CAY10594 CTRPv2 pan-cancer AAC 0.087 0.02
mRNA ML210 CTRPv2 pan-cancer AAC -0.075 0.02
mRNA BRD-K29086754 CTRPv2 pan-cancer AAC 0.17 0.03
mRNA Bortezomib CTRPv2 pan-cancer AAC -0.078 0.03
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.073 0.03
mRNA BRD-K33199242 CTRPv2 pan-cancer AAC 0.084 0.03
mRNA dinaciclib CTRPv2 pan-cancer AAC -0.1 0.03
Download CSV